March 18, 2024 · Form 4 insider transaction
Pizzuti Dana sold 411 shares of Crinetics Pharmaceuticals, Inc. at $38.14 per share, a transaction worth $15.7K. The trade was recorded as shares withheld for taxes under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 1, 2023. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.